bn:00356978n
Noun Concept
Categories: Articles without InChI source, Drugboxes which contain changes to verified fields, Chemicals that do not have a ChemSpider ID assigned, Drugs not assigned an ATC code, Drugboxes which contain changes to watched fields
EN
teplizumab  Teplizumab-mzwv  Tzield
EN
Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 T1D. Wikipedia
Definitions
Relations
Sources
EN
Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 T1D. Wikipedia
Chemical compound Wikidata
Wikipedia
Wikidata
Wikipedia Redirections